Innovative engineering approaches to improve metabolic health
Caltech/UCLA Individualized Theranostic Engineering to Advance Metabolic System (iTEAM)
['FUNDING_TRAINING'] · UNIVERSITY OF CALIFORNIA LOS ANGELES · NIH-10906263
This study is all about training engineers and scientists to use new imaging and sensing technologies to help tackle heart and metabolic diseases, and it's designed to support a diverse group of people who want to make a difference in healthcare.
Quick facts
| Phase | ['FUNDING_TRAINING'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA LOS ANGELES (nih funded) |
| Locations | 1 site (LOS ANGELES, UNITED STATES) |
| Trial ID | NIH-10906263 on ClinicalTrials.gov |
What this research studies
This research focuses on developing advanced imaging and sensing technologies combined with computing to tackle cardiometabolic diseases. The program, a collaboration between Caltech and UCLA, aims to create a structured curriculum that trains engineers and scientists to apply their skills in medical settings. By partnering with industry leaders, the initiative seeks to provide mentorship and internship opportunities, fostering a new generation of professionals equipped to address these health challenges. The program emphasizes diversity and inclusion, ensuring that underrepresented groups are actively involved in this critical field.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by cardiometabolic conditions, such as obesity, diabetes, or cardiovascular diseases.
Not a fit: Patients with non-cardiometabolic conditions or those not interested in technological interventions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies and diagnostic tools that significantly improve the management of cardiometabolic diseases.
How similar studies have performed: Previous research has shown promise in using advanced imaging and sensing technologies for medical applications, indicating a potential for success in this novel approach.
Where this research is happening
LOS ANGELES, UNITED STATES
- UNIVERSITY OF CALIFORNIA LOS ANGELES — LOS ANGELES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HSIAI, TZUNG K — UNIVERSITY OF CALIFORNIA LOS ANGELES
- Study coordinator: HSIAI, TZUNG K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.